Genetic variants involved in innate immunity modulate the risk of inflammatory bowel diseases in an understudied Malaysian population Luu LDW, Popple G, Tsang SPW, Vinasco K, Hilmi I, Ng RT, Chew KS, Wong SY, Riordan S, Lee WS, Mitchell HM, Kaakoush NO, Castaño-Rodríguez N.
Published Dec 2021, in the Journal of gastroenterology and hepatology. Abstract Background and aim: Inflammatory bowel diseases (IBD) are chronic gastrointestinal inflammatory conditions comprising two maj
Association Between Helicobacter pylori Colonization and Inflammatory Bowel Disease: A Systematic Review and Meta-Analysis
Hesamaddin Shirzad-Aski, Sima Besharat, Sabine Kienesberger, Ahmad Sohrabi, Gholamreza Roshandel, Taghi Amiriani, Alireza Norouzi, Aabbas Keshtkar
Published Nov 2021, in the Journal of Clinical Gastroenterology. Background:
Various observational studies have examined a potential relationship between Helicobacter pylori colonization and inflammatory bowel
Short-term effectiveness and safety of tofacitinib in ulcerative colitis - real world data from tertiary medical centers in Israel
Avni-Biron I, Bar-Gil Shitrit A, Koslowsky B, Levartovsky A, Kopylov U, Weisshof R, Aviv Cohen N, Maharshak N, Hovel D, Israeli E, Naftali T, Goren I, Snir Y, Ollech JE, Banai-Eran H, Broitman Y, Sharar-Fischler T, Dotan I, Yanai H.
Published Dec 2021, in the Digestive and liver disease. Abstract Background: We sought to define the effectiveness a
Outcomes of Fecal Microbiota Transplantation for C. difficile Infection in Inflammatory Bowel Disease: A Systematic Review and Meta-analysis
Tariq R, Syed T, Yadav D, Prokop LJ, Singh S, Loftus EV Jr, Pardi DS, Khanna S.
Published Dec 2021, in the Journal of clinical gastroenterology. Abstract Background: Fecal microbiota transplantation (FMT) is a safe and effective therapy for recurrent Clostridioides difficile infection (CDI). Data on FMT for CDI in patients with underlyin
From Bowel inflammation to the Bone and Joints: Rheumatologic examination in Inflammatory Bowel Disease (IBD)
Samane Tavassoli, Seyed Farzam Mirkamali, Iman Shahabinasab, Alireza Norouzi, Taghi Amiriani, Nafiseh Abdolahi, Somayeh Livani, Honey Sadat Mirkarimi, Sima Besharat, Fazel Isapanah Amlashi
Published 2021, in the BMC Musculoskeletal Disorders. Abstract Background: The most common complications in inflammatory Bowel Disease (IBD) are musculoskeletal manifestations that
Tumour necrosis factor inhibitors in inflammatory bowel disease: the story continues
Peyrin-Biroulet L, Sandborn WJ, Panaccione R, Domènech E, Pouillon L, Siegmund B, Danese S, Ghosh S.
Published Dec 2021, in the Digestive and liver disease. Abstract In the 1990s, tumour necrosis factor-α inhibitor therapy ushered in the biologic therapy era for inflammatory bowel disease, leading to marked improvements in treatment options and patient outcomes. There are currently four tumou
COVID-19 vaccine is effective in inflammatory bowel disease patients and is not associated with disease exacerbation Lev-Tzion R, Focht G, Lujan R, Mendelovici A, Friss C, Greenfeld S, Kariv R, Ben-Tov A, Matz E, Nevo D, Barak-Corren Y, Dotan I, Turner D.
Published Dec 2021, in the Clinical gastroenterology and hepatology. Abstract Background & aims: Studies have shown decreased response to coronavirus disease 2019 (COVID-19) vaccinations in some populations. In addition, it
Diagnostic yield of esophagogastroduodenoscopy, colonoscopy, and small bowel endoscopy in Thai adults with chronic diarrhea
Limsrivilai J, Sakjirapapong C, Sattayalertyanyong O, Geeratragool T, Sathirawich P, Pongpaibul A, Apisarnthanarak P, Phaophu P, Subdee N, Charatcharoenwitthaya P, Pausawasdi N.
Published Nov 2021, in the BMC gastroenterology. Abstract Background: Gastrointestinal endoscopy is frequently recommended for chronic diarrhea assessment in Western countries, b
Adherence to mediterranean diet in patients with inflammatory bowel disease
Fiorindi C, Dinu M, Gavazzi E, Scaringi S, Ficari F, Nannoni A, Sofi F, Giudici F.
Published Dec 2021, in the Clinical nutrition ESPEN. Abstract Background & aims: Mediterranean diet may be beneficial for inflammatory bowel disease (IBD). The aim of this study was to evaluate the level of adherence to MD in Italian patients with IBD. Methods: Eighty consecutive outpatients with IBD, 62 with Crohn's Di
The use of personal protective equipment in endoscopy: what should the endoscopist wear during a pandemic?
Jayasena H, Abeynayake D, De Silva A, Niriella M, de Silva HJ.
Published Dec 2021, in the Expert review of gastroenterology and hepatology. Abstract Endoscopists are at high risk of exposure and nosocomial transmission of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2 virus) when performing endoscopic procedures due to the highly aerosol generating nature of
Ustekinumab levels in pregnant women with inflammatory bowel disease and infants exposed in utero
Flanagan E, Prentice R, Wright EK, Gibson PR, Ross AL, Begun J, Sparrow MP, Goldberg R, Rosella O, Burns M, Kiburg KV, Bell SJ.
Published Dec 2021, in the Alimentary pharmacology & therapeutics. Abstract Background: Ustekinumab is increasingly used in pregnant women with inflammatory bowel disease (IBD). Existing safety data are reassuring, but the stability of ustekinumab levels
Challenges in the Pathophysiology, Diagnosis, and Management of Intestinal Fibrosis in Inflammatory Bowel Disease D'Haens G, Rieder F, Feagan BG, Higgins PDR, Panés J, Maaser C, Rogler G, Löwenberg M, van der Voort R, Pinzani M, Peyrin-Biroulet L, Danese S; International Organization for Inflammatory Bowel Disease Fibrosis Working Group.
Published Jan 2022, in the Gastroenterology. Abstract Intestinal fibrosis is a common complication of inflammatory bowel disease (IBD) that